Articles from KRTL Holding Group
Lakewood, CO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- KRTL Holding Group Inc. (OTC: KRTL) ("KRTL Holding" or the "Company") today announced that its subsidiary, KRTL Biotech, Inc., is spotlighting ELIXIR, a high-performance electrolyte hydration beverage, as one of its most commercially successful and strategically positioned consumer health products in the Bolivian Market
By KRTL Holding Group · Via GlobeNewswire · October 2, 2025
Lakewood, CO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC: KRTL) (“KRTL Holding” or the “Company”) today announced that its wholly owned subsidiary, KRTL Biotech, Inc. (“KRTL Biotech”), has completed a merger by exchange of quotas and shares agreement with Industria Químico Farmacéutica Sigma Corp. S.R.L. (“SIGMA”), a leading Bolivian pharmaceutical manufacturer.
By KRTL Holding Group · Via GlobeNewswire · September 9, 2025

Lakewood, CO, June 04, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE
By KRTL Holding Group · Via GlobeNewswire · June 4, 2025
Lakewood, CO, April 09, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE
By KRTL Holding Group · Via GlobeNewswire · April 9, 2025
Lakewood, CO, March 24, 2025 (GLOBE NEWSWIRE) -- KRTL Holding Group Inc. (OTC: KRTL), a diversified holding company operating through its subsidiaries KRTL Biotech, Inc. and KRTL International Corp., is pleased to announce that its wholly owned subsidiary, KRTL Biotech Inc., has signed a Memorandum of Understanding (MOU) with Industria Químico Farmacéutica Sigma Corp. S.R.L. ("Sigma") of Bolivia. This MOU establishes the framework for a strategic international merger between the two pharmaceutical entities.
By KRTL Holding Group · Via GlobeNewswire · March 24, 2025

Lakewood, CO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC: KRTL) is strategically expanding its presence in the heart of South America, where biodiversity flourishes and untapped resources promise new frontiers in medicine. Recognizing Bolivia’s vast potential, KRTL’s subsidiaries, KRTL Biotech, Inc. and KRTL International Corp., have formed a strategic joint venture with Centro de Investigaciones Químicas - CIQ S.R.L., a leading Bolivian research and manufacturing institution led by the esteemed Dr. Bascope.
By KRTL Holding Group · Via GlobeNewswire · February 5, 2025

Lakewood, CO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- KRTL Holding Group Inc. proudly announces the successful registration of Industria Químico Farmaceutica SIGMA CORP. S.R.L. (SIGMA), a premier Bolivian pharmaceutical company, with the United States Food and Drug Administration’s (FDA) Federal Establishment Identifier (FEI). This pivotal milestone highlights the collaboration between KRTL and Sigma in advancing regulatory readiness and enabling access to the highly regulated U.S. market.
By KRTL Holding Group · Via GlobeNewswire · January 22, 2025

Lakewood, CO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- KRTL Holding Group Inc. (OTC: KRTL) announces that its wholly owned subsidiary, KRTL Biotech Inc., has acquired a 55% majority equity stake in Skidmore Companies LLC, now operating as Nutrivance Global. This acquisition, made in consideration of KRTL’s extensive portfolio of Active Pharmaceutical Ingredients (APIs) to be distributed through Nutrivance Global’s established government and private networks, represents a pivotal step in expanding KRTL’s presence in the global healthcare and cosmetics industries. The rebranding of Skidmore Companies to Nutrivance Global reflects a shared commitment to innovation and ambitious growth.
By KRTL Holding Group · Via GlobeNewswire · January 8, 2025

Lakewood, CO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC: KRTL) announces that its subsidiary, KRTL Biotech Inc., has successfully registered Industria Químico Farmaceutica SIGMA CORP. S.R.L. (SIGMACORP) with the U.S. Food and Drug Administration (FDA) as a U.S. pharmaceutical manufacturer. Acting as the U.S. Registered Agent for SIGMACORP, KRTL Biotech marks a significant step in facilitating international pharmaceutical integration and diversifying the U.S. healthcare supply chain.
By KRTL Holding Group · Via GlobeNewswire · December 5, 2024

KRTL Biotech Achieves FDA Registration, Advancing Global Pharmaceutical Access and U.S. Supply Chain Resilience
By KRTL Holding Group · Via GlobeNewswire · November 26, 2024

Lakewood, CO, July 18, 2023 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC: KRTL), a holding company with two subsidiaries, is pleased to announce that its wholly owned subsidiary KRTL International Corp. (“KRTL”), has entered into a partnership with GIH Life Sciences, LLC, and Industria Quimico Farmaceutica SigmaCorp, LLC in Bolivia and are pleased to announce the signing of a tripartite collaboration agreement. This agreement aims to establish a mutually beneficial relationship that will facilitate the sharing of business practices, general business ventures, and strategic partnership agendas. Together, these industry leaders will leverage their combined expertise to assist in the emerging CBD/THC research industry in Bolivia and explore other strategic opportunities, enabling a mutual competitive advantage.
By KRTL Holding Group · Via GlobeNewswire · July 18, 2023

Lakewood, CO, May 30, 2023 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC:KRTL), an innovator and pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
By KRTL Holding Group · Via GlobeNewswire · May 30, 2023

Lakewood, CO, Dec. 05, 2022 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC: KRTL) an innovator and pioneer in developing industry leading cross-over tradecraft and proprietary technology and methodology in the hemp, cannabis, psilocybin, and alternative wellness sectors, is pleased to announce that its wholly owned subsidiaries, KRTL International Corp and KRTL Biotech Inc. (“KRTL”), have entered into a memorandum of understanding (MOU) for the development of industry-differentiated commercial CBD and other cannabinoid based products with Yuhan Care, a subsidiary of Yuhan Corporation, a global pharmaceutical company founded in 1926. Inspired by the hardship that their founder Dr. Ilhan witnessed under Japanese Imperialism, Yuhan Corporation was started with the belief that only healthy people could reclaim their sovereignty and he sought to solve widespread public health problems based on that mission.
By KRTL Holding Group · Via GlobeNewswire · December 5, 2022

Lakewood, CO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- KRTL Holding Group is very excited to welcome Mr. David Beling as a new Strategic Advisor. Mr. Beling is a 1964 Mining Engineering graduate from the University of Arizona and has been employed and/or consulted for Phelps Dodge, Union Oil, Fluor, United Technologies, Westinghouse, and 30+ Canadian and US junior mining companies. He served on the Boards of 14 Canadian and US mining companies beginning in 1981 and continues to serve as a director of NioCorp Developments Ltd.
By KRTL Holding Group · Via GlobeNewswire · October 13, 2022

Lakewood, CO, Oct. 06, 2022 (GLOBE NEWSWIRE) -- KRTL International Corp., a wholly owned subsidiary of KRTL Holding Group, Inc. (OTC: KRTL), proudly announces it has formed a global strategic alliance with Cannabis Global, Inc. (OTC: CBGL), focusing on one of the fastest growing areas of the hemp and cannabis marketplaces: infusion technologies including, water soluble formulations to be used in a host of commercial products. The new relationship between the companies will also include other areas of research and development specific to hemp and cannabis consumer products.
By KRTL Holding Group · Via GlobeNewswire · October 6, 2022